A phase III study of high dose radiation therapy with or without cetuximab in patients with locoregionally advanced squamous cell carcinoma of the head and neck

被引:0
|
作者
Giralt, J
Haran, PM
Ang, KK
Azarnia, N
Cohen, RB
Kies, MS
Jassem, J
Harstick, A
Baselga, J
Bonner, JA
机构
[1] Vall Hebron Univ Hosp, Barcelona, Spain
[2] Univ Wisconsin, Madison, WI USA
[3] UT MD Anderson Canc Ctr, Houston, TX USA
[4] ImClone Syst, Somerville, NJ USA
[5] Univ Virginia, Charlottesville, VA USA
[6] Med Univ, Gdansk, Poland
[7] Merck KGaA, Darmstadt, Germany
[8] Univ Alabama, Birmingham, AL USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S127 / S127
页数:1
相关论文
共 50 条
  • [21] Results of an international phase III trial of radiation ± Cetuximab (Erbitux™) in patients with locoregionally advanced head & neck (H&N) cancer
    Harari, Paul M.
    Giralt, Jordi L.
    Chinnaiyan, Prakash
    Azarnia, Nosar
    Molloy, Patricia
    Cohen, Roger
    Raben, David
    Jones, Christopher
    Kies, Merrill S.
    Baselga, Jose
    Ang, Kian K.
    Bonner, James A.
    ANNALS OF ONCOLOGY, 2004, 15 : 13 - 13
  • [22] Prognostic Significance of Plasma Osteopontin in Patients with Locoregionally Advanced Head and Neck Squamous Cell Carcinoma Treated on TROG 02.02 Phase III Trial
    Lim, Annette M.
    Rischin, Danny
    Fisher, Richard
    Cao, Hongbin
    Kwok, Kathleen
    Truong, Daniel
    McArthur, Grant A.
    Young, Richard J.
    Giaccia, Amato
    Peters, Lester
    Le, Quynh-Thu
    CLINICAL CANCER RESEARCH, 2012, 18 (01) : 301 - 307
  • [23] Advanced Squamous Cell Carcinoma of the Head and Neck: The Current Role of Cetuximab
    Granados-Garcia, Martin
    Luis Aguilar-Ponce, Jose
    Maldonado-Magos, Federico
    De la Garza-Salazar, Jaime G.
    ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY HEAD AND NECK SURGERY, 2016, 78 (06): : 320 - 333
  • [24] Xevinapant with radiation and concurrent carboplatin and paclitaxel in patients ineligible for cisplatin with locoregionally advanced squamous cell carcinoma of the head and neck (EXtRaCT study)
    Mir, Nabiel Ali
    Juloori, Aditya
    Swiecicki, Paul
    Katipally, Rohan Reddy
    Agrawal, Nishant
    Blair, Elizabeth A.
    Haraf, Daniel J.
    Pearson, Alexander T.
    Vokes, Everett E.
    Rosenberg, Ari Joseph
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [25] Single-Arm Phase 2 Trial of Elective Nodal Dose Reduction for Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck
    Maguire, Patrick D.
    Neal, Charles R.
    Hardy, Stuart M.
    Schreiber, Andrew M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 100 (05): : 1210 - 1216
  • [26] Methotrexate and cetuximab for metastatic advanced head and neck squamous cell carcinoma: A retrospective study
    Atassi, Bassel
    Alsibai, Khaled
    Yoo, George H.
    Lin, Ho-Sheng
    Dyson, Gregory
    Kim, Harold
    Jacobs, John Robert
    Kucuk, Omer
    Sukari, Ammar
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [27] Immunological Treatment Options for Locoregionally Advanced Head and Neck Squamous Cell Carcinoma
    Schutt, Christopher
    Bumm, Klaus
    Mirandola, Leonardo
    Bernardini, Giovanni
    D' Cunha, Nicholas
    Tijani, Lukman
    Diane Nguyen
    Cordero, Joehassin
    Jenkins, Marjorie R.
    Cobos, Everardo
    Kast, W. Martin
    Chiriva-Internati, Maurizio
    INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2012, 31 (01) : 22 - 42
  • [28] Prospective Study of Cetuximab, Carboplatin, and Radiation Therapy for Patients With Locally Advanced Head and Neck Squamous Cell Cancer Unfit for Cisplatin
    Corry, June
    Bressel, Mathias
    Fua, Tsien
    Herschtal, Alan
    Solomon, Benjamin
    Porceddu, Sandro V.
    Wratten, Chris
    Rischin, Danny
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (04): : 948 - 954
  • [29] Cisplatin versus Cetuximab Given Concurrently with Definitive Radiation Therapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
    Ley, Jessica
    Mehan, Paul
    Wildes, Tanya M.
    Thorstad, Wade
    Gay, Hiram A.
    Michel, Loren
    Nussenbaum, Brian
    Trinkaus, Kathryn
    Adkins, Douglas
    ONCOLOGY, 2013, 85 (05) : 290 - 296
  • [30] Phase I Trial of Bevacizumab followed by Concurrent Radiation, Bevacizumab and Cisplatin for Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck
    Harari, P. M.
    Khuntia, D.
    Traynor, A. M.
    Hoang, T.
    Hartig, G. K.
    McCulloch, T. M.
    Jeraj, R.
    Nyflot, M.
    Wiederholt, P. A.
    Gentry, L. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S104 - S104